Intercept Pharmaceuticals
ICPT
#5906
Rank
ยฃ0.63 B
Marketcap
ยฃ15.13
Share price
0.00%
Change (1 day)
-8.03%
Change (1 year)

Revenue for Intercept Pharmaceuticals (ICPT)

Revenue in 2023 (TTM): ยฃ0.25 Billion

According to Intercept Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ0.25 Billion. In 2022 the company made a revenue of ยฃ0.26 Billion a decrease over the revenue in the year 2021 that were of ยฃ0.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intercept Pharmaceuticals from 2012 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ0.25 B-1.01%
2022 ยฃ0.26 B-3.26%
2021 ยฃ0.26 B17.38%
2020 ยฃ0.22 B19.37%
2019 ยฃ0.19 B35.67%
2018 ยฃ0.14 B46.19%
2017 ยฃ96.89 M379.18%
2016 ยฃ20.22 M976.99%
2015 ยฃ1.87 M67.92%
2014 ยฃ1.11 M13.73%
2013 ยฃ0.98 M-35.03%
2012 ยฃ1.51 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ32.53 B 12,762.88%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.76 B 14,831.50%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.13 B 8,651.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.79 M-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA